Dec 21, 2023 05:09PM
Jan 18, 2022 07:00AM
Jan 18, 2022 07:00AM
Jan 18, 2022 07:00AM
Apr 30, 2020 08:00AM
Apr 28, 2020 04:30PM
Mar 3, 2020 08:00AM Magenta Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights
Feb 26, 2020 08:30AM
Feb 24, 2020 08:31AM
Feb 24, 2020 08:30AM
Feb 24, 2020 08:30AM
Feb 20, 2020 08:37AM
Feb 20, 2020 08:30AM
Feb 6, 2020 08:30AM Magenta Therapeutics to Participate in Guggenheim Healthcare Talks Oncology Day on Thursday, February 13th in New York City
Feb 5, 2020 08:30AM
Jan 6, 2020 08:30AM
Dec 9, 2019 07:46AM
Dec 9, 2019 07:45AM
Dec 7, 2019 05:30PM
Nov 26, 2019 04:05PM
Nov 13, 2019 08:00AM Magenta Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
Nov 11, 2019 08:31AM
Nov 11, 2019 08:30AM
Nov 6, 2019 09:00AM
Oct 16, 2019 08:30AM
Sep 4, 2019 08:32AM
Sep 4, 2019 08:30AM
Aug 8, 2019 08:00AM Magenta Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights
Aug 6, 2019 08:30AM
Jun 6, 2019 04:05PM
May 9, 2019 08:00AM
May 9, 2019 07:43AM
May 9, 2019 07:30AM
Apr 29, 2019 04:14PM
Apr 29, 2019 08:00AM Magenta Therapeutics to Present Preclinical Data on E478 Stem Cell Gene Therapy Expansion Program at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy
Apr 24, 2019 08:32AM
Apr 24, 2019 08:30AM
Mar 19, 2019 07:30AM
Mar 6, 2019 04:05PM
Feb 25, 2019 08:17AM
Feb 25, 2019 08:16AM
Feb 25, 2019 08:15AM Magenta Therapeutics Presents Clinical and Preclinical Data on MGTA-456 Cell Therapy in Best Abstracts Sessions at Transplant and Cellular Therapy (TCT) Annual Meeting
Feb 25, 2019 08:15AM
Feb 21, 2019 08:00AM
Feb 7, 2019 08:30AM
Jan 2, 2019 08:30AM
Dec 3, 2018 05:53AM
Dec 2, 2018 09:00PM
Dec 2, 2018 09:00PM Magenta Therapeutics Presents New Data from Phase 2 Study of MGTA-456 Cell Therapy in Patients with Inherited Metabolic Disorders
Dec 1, 2018 12:30PM

64,524 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All